A device for delivering a predetermined amount of at least one substance to a body orifice of a subject includes a) a container for containing said at least one substance; b) a delivery end for placement in proximity to the orifice, the delivery end being in fluid communication with the container; c) a valve mechanically connectable to said container, characterized by at least two configurations: (i) an ACTIVE CONFIGURATION in which said valve enables delivery of predetermined amount of said substance from said container to said body orifice via said delivery end; and, (ii) an INACTIVE CONFIGURATION, in which said valve prevents delivery of said predetermined amount of said substance from said container to said body orifice; d) a trigger mechanism adapted to reconfigure said valve from said INACTIVE CONFIGURATION to said ACTIVE CONFIGURATION, and vice versa; and e) a fluid tight chamber.

A dry powder inhaler is disclosed. The dry powder inhaler includes a first housing member and a second housing member being rotatable in relation to one another to prepare administering a medicament dose from at least one medicament reservoir. An air inlet, a first air outlet, and a second air outlet are provided. The air inlet and the first air outlet are connected by a first air channel via a dosage mechanism configured to arrange a dose from the reservoir into the first air channel. The air inlet and the second air outlet are connected by a second air channel. An inhalation chimney is provided internally forming the proximal portion of the first air channel and comprising the first air outlet at a first end thereof.

Provided is a blister pack for a dry powder inhaler configured to deliver a first powder medicament and a second powder medicament different from the first powder medicament. The first and second powder medicaments are contained within blister pockets defined in a strip. A series of blister pockets is defined in the strip, which series extends linearly along the length of the strip. The first and second powder medicaments are contained in blister pockets of the series. Alternatively or additionally, each of the blister pockets is elongated such as to have a largest dimension parallel with the length of the strip. These measures, either individually or in combination, enable minimizing of the width of the strip in spite of the strip accommodating both the first and second powder medicaments.

A stand-alone chamber or multi-chamber inhalation system has at least two alternative vaporized test liquid supply systems for passive or self-administered delivery of vaporized test fluid and air to one or more test chambers, which can be passive or restraint chambers, based on operator selection of delivery on and off times in a passive mode or actuation of an actuator in the chamber by a test animal in a self-administered mode. In one case, a multiple inhalation chamber system has two or more separate test fluid delivery systems and provides options for selective passive uniform drug delivery to multiple chambers or selective delivery of two or more different drugs to different groups of chambers from different delivery systems so that two different drugs or different concentrations of delivered drugs can be tested simultaneously.

In general, drug administration devices configured to communicate with networks and external devices are provided. In an exemplary embodiment, a drug administration device is configured to adjust an operational parameter of the drug administration device based on a data packet formed from drug administration data ancillary data received from networks and/or external devices. In another example embodiment, a drug administration device is configured to scan for and establish communications with at least one external device. In another example embodiment, a method includes assessing whether to update a control program on a drug administration device from a network or external device. In another example embodiment, a system includes a first drug administration device configured to communicate with a second drug administration device to optimize a drug treatment.

Provided is an electronic atomization apparatus in the technical field of atomization. The electronic atomization apparatus includes a main unit and an atomizer. The main unit includes a housing component, a control assembly, and a battery assembly. The control assembly and the battery assembly are disposed inside the housing component. The control assembly is electrically connected to the battery assembly. The atomizer includes an atomization housing and a heating circuit disposed inside the atomization housing. One end of the atomization housing is connected to one end of the housing component. The atomization housing is provided with at least two atomization compartments that are independent of each other. The heating circuit is electrically connected to the control assembly. Another end of the atomization housing is provided with a gas outlet. The gas outlet may selectively communicate with one of the at least two atomization compartments.

An aerosol delivery system including a first engagement mechanism, a first power supply, and a first vaporizer, wherein the first vaporizer is arranged to selectively receive power from the first power supply to generate a first aerosol from a first aerosol precursor material for user inhalation; and a second aerosol delivery device including a second engagement mechanism, a second power supply, and a second vaporizer, wherein the second vaporizer is arranged to selectively receive power from the second power supply to generate a second aerosol from a second aerosol precursor material for user inhalation; wherein the first engagement mechanism of the first aerosol delivery device and the second engagement mechanism of the second aerosol delivery device are arranged to releasably co-engage with one another to selectively couple the first aerosol delivery device to the second aerosol delivery device so the first aerosol delivery device and the second aerosol delivery device may be used together to deliver the first and second aerosols to a single user when they are coupled together and may be used independently to deliver the first and second aerosols to different users when they are not coupled together.

An aerosol-generating system includes a plurality of cartridges and an aerosol-generating device. At least one cartridge of the plurality of cartridges includes a first aerosol-forming substrate, the plurality of cartridges are configured for selective connection to each other to form a cartridge assembly. The aerosol-generating device includes a storage including a second aerosol-forming substrate in the storage, an electric heater configured to heat a portion of the second aerosol-forming substrate from the storage section during use of the aerosol-generating system, and a power supply housing, the power supply housing including a power supply and a controller, the controller configured to control a supply of electrical power from the power supply to the electric heater, the aerosol-generating device being configured to receive the cartridge assembly at a downstream end of the aerosol-generating device.

A test fixture for testing aerosol provision devices may include a housing, a plurality of testing modules disposed at the housing where each of the testing modules includes a cavity configured to receive a portion of an aerosol provision device, and processing circuitry operably coupled to the testing modules. Each of the testing modules may be configured to interface with an assembly of a respective one of the aerosol provision devices to transition the assembly between an initial state and a transitioned state during a functional test controlled by the processing circuitry. The processing circuitry may be configured to conduct the functional test of at least two of the testing modules simultaneously.

The present invention provides for the integration of drug dispersion methods into a drug or medicine delivery system. The drug dispersion methods used include shear (e.g., air across a drug, with or without a gas assist), capillary flow or a venturi effect, mechanical means such as spinning, vibration, or impaction, and turbulence (e.g., using mesh screens, or restrictions in the air path). These methods of drug dispersion allow for all of the drug in the system to be released, allowing control of the dosage size. These methods also provide for drug metering, fluidization, entrainment, deaggragation and deagglomeration. The present invention also provides for the integration of a drug sealing system into the device. The drug sealing system provides a way of blocking the migration of drug from one area of the package to another. The drug seal system can also provide a method of tightly containing the drug until the package is opened, of directing airflow through the package and of managing and containing the drug during the package/device manufacturing process.